Locke Lord Welcomes Partner Daniel Peters in Los Angeles as Member of Corporate and Transactional Department

Tuesday, March 19, 2013

Daniel H. Peters has joined Locke Lord’s Los Angeles office as a Partner in the Corporate Practice, where his domestic and international M&A focus will help bolster the Firm’s California Corporate platform as well as contribute to the corporate team firm-wide. Peters is a seasoned international transactional attorney with extensive experience counseling strategic buyers and sellers in domestic and cross-border acquisitions, including both public and private target companies.

More >>

Tags:  Locke Lord LLP | Los Angeles

Baker Botts – CenterPoint Energy Enters Into Midstream Joint Venture With OGE Energy, ArcLight Capital Partners

Tuesday, March 19, 2013

On March 14, 2013, CenterPoint Energy, Inc., OGE Energy Corp. and ArcLight Capital Partners, LLC announced that they have entered into an agreement to form a joint venture that will include CenterPoint Energy’s interstate pipelines and field services businesses and the midstream business of Enogex LLC, which is owned jointly by subsidiaries of OGE Energy and ArcLight.

More >>

Tags:  Baker Botts L.L.P. | Houston

O’Melveny Represents BGI-Shenzhen in Acquisition of Complete Genomics

Tuesday, March 19, 2013

O’Melveny & Myers LLP represented leading international genomics organization BGI-Shenzhen (BGI) in its acquisition via all cash tender offer, followed by a short form merger, of Nasdaq listed Complete Genomics (Complete). The deal closed on March 18, 2013. It has been reported as the first time a Chinese company has successfully acquired a US public company.

More >>

Tags:  O'Melveny & Myers, LLP | Shanghai

Dorsey Adds Experienced Corporate, M&A Practice Partner To Its Denver Office

Tuesday, March 19, 2013

International law firm Dorsey & Whitney LLP announced today that Whitney Holmes has joined the Corporate practice in the Firm’s Denver office as a Partner. Mr. Holmes concentrates his practice on general corporate matters, capital markets and mergers & acquisitions. He has extensive experience representing clients in corporate finance transactions including public offerings and private placements of equity and debt, bank credit, structured and venture capital financings. Mr. Holmes’ clients span a broad range of industries including energy, health care, pharmaceuticals, high-tech manufacturing, telecommunications, software and financial services.

More >>

Tags:  Dorsey & Whitney LLP | Denver

Davis Polk – Silver Spring Networks Initial Public Offering

Tuesday, March 19, 2013

Davis Polk advised Goldman, Sachs & Co. and Credit Suisse Securities (USA) LLC as representatives of the several underwriters on the $92.86 million initial public offering of 5,462,500 shares of common stock of Silver Spring Networks, Inc., including 712,500 shares from the full exercise of the underwriters’ option to purchase additional shares. Silver Spring Networks’s common stock is traded on the New York Stock Exchange under the symbol “SSNI.”

More >>

Tags:  Davis Polk & Wardwell LLP | Silicon Valley

Davis Polk – Yandex N.V. $600 Million Secondary Offering

Tuesday, March 19, 2013

Davis Polk advised Morgan Stanley & Co. International plc, Deutsche Bank Securities Inc. and Goldman, Sachs & Co. as underwriters in connection with the SEC-registered secondary offering of 26,679,386 Class A shares of Yandex N.V., including 2,425,399 additional Class A shares sold pursuant to an option granted to the underwriters. The public offering price was $22.75 per share, and the total gross proceeds to the selling shareholders amounted to $600 million. The Class A shares are listed on the Nasdaq Global Select Market under the symbol “YNDX.”

More >>

Tags:  Davis Polk & Wardwell LLP | New York

Cravath – AmerisourceBergen’s Strategic Relationship with Walgreens and Alliance Boots

Tuesday, March 19, 2013

On March 19, 2013, AmerisourceBergen Corporation announced that it is entering into a strategic, long‑term relationship with Walgreen Co. and Alliance Boots GmbH, which will streamline the distribution of pharmaceuticals to Walgreens stores and leverage global supply chain efficiencies while improving patient access to affordable pharmaceuticals to increase the efficiency of the healthcare system. Cravath represented AmerisourceBergen in this transaction.

More >>

Tags:  Cravath, Swaine & Moore LLP | New York